The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Carcinoembryonic Antigen (CEA) Market Research Report 2024
Synopsis
Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion.
The global Carcinoembryonic Antigen (CEA) market was valued at US$ 1753.7 million in 2023 and is anticipated to reach US$ 2328 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
Increasing consumption of alcohol and sedentary lifestyle are likely to boost the growth of colorectal cancer over the forecast period.
This report aims to provide a comprehensive presentation of the global market for Carcinoembryonic Antigen (CEA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carcinoembryonic Antigen (CEA).
Report Scope
The Carcinoembryonic Antigen (CEA) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Carcinoembryonic Antigen (CEA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carcinoembryonic Antigen (CEA) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Diagnostics
Abbott Diagnostics
Quest Diagnostics
Segment by Type
CD66a
CD66b
CD66c
CD66d
CD66e
CD66f
Segment by Application
Colorectal Cancer
Pancreatic Cancer
Ovarian Cancer
Breast Cancer
Thyroid Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Carcinoembryonic Antigen (CEA) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion.
The global Carcinoembryonic Antigen (CEA) market was valued at US$ 1753.7 million in 2023 and is anticipated to reach US$ 2328 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
Increasing consumption of alcohol and sedentary lifestyle are likely to boost the growth of colorectal cancer over the forecast period.
This report aims to provide a comprehensive presentation of the global market for Carcinoembryonic Antigen (CEA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carcinoembryonic Antigen (CEA).
Report Scope
The Carcinoembryonic Antigen (CEA) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Carcinoembryonic Antigen (CEA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carcinoembryonic Antigen (CEA) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Diagnostics
Abbott Diagnostics
Quest Diagnostics
Segment by Type
CD66a
CD66b
CD66c
CD66d
CD66e
CD66f
Segment by Application
Colorectal Cancer
Pancreatic Cancer
Ovarian Cancer
Breast Cancer
Thyroid Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Carcinoembryonic Antigen (CEA) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CD66a
1.2.3 CD66b
1.2.4 CD66c
1.2.5 CD66d
1.2.6 CD66e
1.2.7 CD66f
1.3 Market by Application
1.3.1 Global Carcinoembryonic Antigen (CEA) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Colorectal Cancer
1.3.3 Pancreatic Cancer
1.3.4 Ovarian Cancer
1.3.5 Breast Cancer
1.3.6 Thyroid Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Carcinoembryonic Antigen (CEA) Market Perspective (2019-2030)
2.2 Carcinoembryonic Antigen (CEA) Growth Trends by Region
2.2.1 Global Carcinoembryonic Antigen (CEA) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Carcinoembryonic Antigen (CEA) Historic Market Size by Region (2019-2024)
2.2.3 Carcinoembryonic Antigen (CEA) Forecasted Market Size by Region (2025-2030)
2.3 Carcinoembryonic Antigen (CEA) Market Dynamics
2.3.1 Carcinoembryonic Antigen (CEA) Industry Trends
2.3.2 Carcinoembryonic Antigen (CEA) Market Drivers
2.3.3 Carcinoembryonic Antigen (CEA) Market Challenges
2.3.4 Carcinoembryonic Antigen (CEA) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Carcinoembryonic Antigen (CEA) Players by Revenue
3.1.1 Global Top Carcinoembryonic Antigen (CEA) Players by Revenue (2019-2024)
3.1.2 Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Players (2019-2024)
3.2 Global Carcinoembryonic Antigen (CEA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Carcinoembryonic Antigen (CEA) Revenue
3.4 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio
3.4.1 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Carcinoembryonic Antigen (CEA) Revenue in 2023
3.5 Carcinoembryonic Antigen (CEA) Key Players Head office and Area Served
3.6 Key Players Carcinoembryonic Antigen (CEA) Product Solution and Service
3.7 Date of Enter into Carcinoembryonic Antigen (CEA) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Carcinoembryonic Antigen (CEA) Breakdown Data by Type
4.1 Global Carcinoembryonic Antigen (CEA) Historic Market Size by Type (2019-2024)
4.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Type (2025-2030)
5 Carcinoembryonic Antigen (CEA) Breakdown Data by Application
5.1 Global Carcinoembryonic Antigen (CEA) Historic Market Size by Application (2019-2024)
5.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Carcinoembryonic Antigen (CEA) Market Size (2019-2030)
6.2 North America Carcinoembryonic Antigen (CEA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Carcinoembryonic Antigen (CEA) Market Size by Country (2019-2024)
6.4 North America Carcinoembryonic Antigen (CEA) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Carcinoembryonic Antigen (CEA) Market Size (2019-2030)
7.2 Europe Carcinoembryonic Antigen (CEA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Carcinoembryonic Antigen (CEA) Market Size by Country (2019-2024)
7.4 Europe Carcinoembryonic Antigen (CEA) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size (2019-2030)
8.2 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Region (2019-2024)
8.4 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Carcinoembryonic Antigen (CEA) Market Size (2019-2030)
9.2 Latin America Carcinoembryonic Antigen (CEA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Carcinoembryonic Antigen (CEA) Market Size by Country (2019-2024)
9.4 Latin America Carcinoembryonic Antigen (CEA) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size (2019-2030)
10.2 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Country (2019-2024)
10.4 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Detail
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Carcinoembryonic Antigen (CEA) Introduction
11.1.4 Roche Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2019-2024)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott Diagnostics
11.2.1 Abbott Diagnostics Company Detail
11.2.2 Abbott Diagnostics Business Overview
11.2.3 Abbott Diagnostics Carcinoembryonic Antigen (CEA) Introduction
11.2.4 Abbott Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2019-2024)
11.2.5 Abbott Diagnostics Recent Development
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Detail
11.3.2 Quest Diagnostics Business Overview
11.3.3 Quest Diagnostics Carcinoembryonic Antigen (CEA) Introduction
11.3.4 Quest Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2019-2024)
11.3.5 Quest Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
